Clinical Trial Update: Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tislelizumab in combination with chemotherapy or radiotherapy for advanced or recurrent metastatic elderly esophageal cancer; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: NOT_YET_RECRUITING